Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Total Non-current Liabilities
All obligations due after more than one year.
No reported Total Non-current Liabilities figures are available to summarize.
Total Non-current Liabilities history
Currency unavailable · from the balance sheet
No Total Non-current Liabilities data reported for this period type.
Total Non-current Liabilities vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $275.24M USD | -20.0% | -3.6% | 83.5% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $32.23M USD | -19.5% | -49.5% | 5.7% |
| Mar 2026 | $27.7M USD | -14.8% | -6.4% | 13.9% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €9.19M EUR | — | — | 5.5% |
| Sep 2026 | $8.05M USD | +149.2% | -14.5% | 0.7% | |
| Jun 2026 | $6.82M USD | -52.9% | +104.4% | 0.8% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $2.09M USD | +40.3% | +67.4% | 0.2% |
| Mar 2026 | $146K USD | -30.5% | -52.4% | 0.1% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -19.5% | -6.4% | 3.2% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.